APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthesia Drugs

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Selected research

Industry Growth & Trends

Global General Anesthesia Drugs Industry Growth and Trends Forecast to 2032

2 January 2026103 pages

Choose your research edition.

Industry ResearchGeneral Anesthesia Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthesia Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthesia Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthesia Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global General Anesthesia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The General Anesthesia Drugs market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global General Anesthesia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to General Anesthesia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global General Anesthesia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

General Anesthesia Drugs Market by Company

Astrazeneca

Fresenius-Kabi

AbbVie

Baxter Healthcare

B.Braun

Maruishi

Piramal

Hikma Pharmaceuticals

Mylan

Nhwa

Hengrui

Lunan

General Anesthesia Drugs Segment by Type

Propofol

Etomidate

Midazolam

Sevoflurane

Isoflurane

Others

General Anesthesia Drugs Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Propofol Table 2. Major Company of Etomidate Table 3. Major Company of Midazolam Table 4. Major Company of Sevoflurane Table 5. Major Company of Isoflurane Table 6. Major Company of Others Table 7. Global General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 9. Global General Anesthesia Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global General Anesthesia Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global General Anesthesia Drugs Price by Type (2021-2026) & (US$/L) Table 13. Global General Anesthesia Drugs Sales by Type (2027-2032) & (K L) Table 14. Global General Anesthesia Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global General Anesthesia Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global General Anesthesia Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global General Anesthesia Drugs Price by Type (2027-2032) & (US$/L) Table 18. North America General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 19. North America General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 21. Europe General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 23. Asia-Pacific General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 25. Latin America General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 27. Middle East and Africa General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. General Anesthesia Drugs Industry Trends Table 29. General Anesthesia Drugs Industry Drivers Table 30. General Anesthesia Drugs Industry Opportunities and Challenges Table 31. General Anesthesia Drugs Industry Restraints Table 32. Global General Anesthesia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global General Anesthesia Drugs Revenue Market Share by Company (2021-2026) Table 34. Global General Anesthesia Drugs Sales by Company (2021-2026) & (K L) Table 35. Global General Anesthesia Drugs Sales Share by Company (2021-2026) Table 36. Global General Anesthesia Drugs Market Price by Company (2021-2026) & (US$/L) Table 37. Global General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global General Anesthesia Drugs Major Company Production Sites and Headquarters Table 39. Global General Anesthesia Drugs Company, Product Type & Application Table 40. Global General Anesthesia Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global General Anesthesia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global General Anesthesia Drugs Sales by Region (2021-2026) & (K L) Table 45. Global General Anesthesia Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global General Anesthesia Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global General Anesthesia Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 49. Global General Anesthesia Drugs Sales by Region (2027-2032) & (K L) Table 50. Global General Anesthesia Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global General Anesthesia Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global General Anesthesia Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global General Anesthesia Drugs Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 54. Global General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 56. Global General Anesthesia Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global General Anesthesia Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global General Anesthesia Drugs Price by Application (2021-2026) & (US$/L) Table 60. Global General Anesthesia Drugs Sales by Application (2027-2032) & (K L) Table 61. Global General Anesthesia Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global General Anesthesia Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global General Anesthesia Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global General Anesthesia Drugs Price by Application (2027-2032) & (US$/L) Table 65. North America General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 66. North America General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 68. Europe General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 70. Asia-Pacific General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 72. Latin America General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 74. Middle East and Africa General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Astrazeneca Company Information Table 76. Astrazeneca Business Overview Table 77. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 78. Astrazeneca General Anesthesia Drugs Product Portfolio Table 79. Astrazeneca Recent Development Table 80. Fresenius-Kabi Company Information Table 81. Fresenius-Kabi Business Overview Table 82. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 83. Fresenius-Kabi General Anesthesia Drugs Product Portfolio Table 84. Fresenius-Kabi Recent Development Table 85. AbbVie Company Information Table 86. AbbVie Business Overview Table 87. AbbVie General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 88. AbbVie General Anesthesia Drugs Product Portfolio Table 89. AbbVie Recent Development Table 90. Baxter Healthcare Company Information Table 91. Baxter Healthcare Business Overview Table 92. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 93. Baxter Healthcare General Anesthesia Drugs Product Portfolio Table 94. Baxter Healthcare Recent Development Table 95. B.Braun Company Information Table 96. B.Braun Business Overview Table 97. B.Braun General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 98. B.Braun General Anesthesia Drugs Product Portfolio Table 99. B.Braun Recent Development Table 100. Maruishi Company Information Table 101. Maruishi Business Overview Table 102. Maruishi General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 103. Maruishi General Anesthesia Drugs Product Portfolio Table 104. Maruishi Recent Development Table 105. Piramal Company Information Table 106. Piramal Business Overview Table 107. Piramal General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 108. Piramal General Anesthesia Drugs Product Portfolio Table 109. Piramal Recent Development Table 110. Hikma Pharmaceuticals Company Information Table 111. Hikma Pharmaceuticals Business Overview Table 112. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 113. Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio Table 114. Hikma Pharmaceuticals Recent Development Table 115. Mylan Company Information Table 116. Mylan Business Overview Table 117. Mylan General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 118. Mylan General Anesthesia Drugs Product Portfolio Table 119. Mylan Recent Development Table 120. Nhwa Company Information Table 121. Nhwa Business Overview Table 122. Nhwa General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 123. Nhwa General Anesthesia Drugs Product Portfolio Table 124. Nhwa Recent Development Table 125. Hengrui Company Information Table 126. Hengrui Business Overview Table 127. Hengrui General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 128. Hengrui General Anesthesia Drugs Product Portfolio Table 129. Hengrui Recent Development Table 130. Lunan Company Information Table 131. Lunan Business Overview Table 132. Lunan General Anesthesia Drugs Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 133. Lunan General Anesthesia Drugs Product Portfolio Table 134. Lunan Recent Development Table 135. North America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 136. North America General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 137. North America General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 138. North America General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K L) Table 139. North America General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 140. North America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. North America General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 142. North America General Anesthesia Drugs Market Share by Country (2021-2026) Table 143. North America General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. North America General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 145. Europe General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 146. Europe General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 147. Europe General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 148. Europe General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K L) Table 149. Europe General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 150. Europe General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Europe General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 152. Europe General Anesthesia Drugs Market Share by Country (2021-2026) Table 153. Europe General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Europe General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 157. Asia-Pacific General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 158. Asia-Pacific General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K L) Table 159. Asia-Pacific General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 160. Asia-Pacific General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Asia-Pacific General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 162. Asia-Pacific General Anesthesia Drugs Market Share by Country (2021-2026) Table 163. Asia-Pacific General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Asia-Pacific General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 165. Latin America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 166. Latin America General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 167. Latin America General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 168. Latin America General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K L) Table 169. Latin America General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 170. Latin America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Latin America General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 172. Latin America General Anesthesia Drugs Market Share by Country (2021-2026) Table 173. Latin America General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Latin America General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 177. Middle East and Africa General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 178. Middle East and Africa General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (K L) Table 179. Middle East and Africa General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 180. Middle East and Africa General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Middle East and Africa General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 182. Middle East and Africa General Anesthesia Drugs Market Share by Country (2021-2026) Table 183. Middle East and Africa General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Middle East and Africa General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. General Anesthesia Drugs Distributors List Table 188. General Anesthesia Drugs Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. General Anesthesia Drugs Image Figure 2. Global General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global General Anesthesia Drugs Sales (2021-2032) & (K L) Figure 5. Propofol Image Figure 6. Global Propofol Sales YoY Growth (2021-2032) & (K L) Figure 7. Etomidate Image Figure 8. Global Etomidate Sales YoY Growth (2021-2032) & (K L) Figure 9. Midazolam Image Figure 10. Global Midazolam Sales YoY Growth (2021-2032) & (K L) Figure 11. Sevoflurane Image Figure 12. Global Sevoflurane Sales YoY Growth (2021-2032) & (K L) Figure 13. Isoflurane Image Figure 14. Global Isoflurane Sales YoY Growth (2021-2032) & (K L) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K L) Figure 17. Global General Anesthesia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global General Anesthesia Drugs Market Share by Type 2025 VS 2032 Figure 19. North America General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Intravenous Anesthetics Image Figure 32. Global Intravenous Anesthetics Sales YoY Growth (2021-2032) & (K L) Figure 33. Inhalational Anesthetics Image Figure 34. Global Inhalational Anesthetics Sales YoY Growth (2021-2032) & (K L) Figure 35. Global General Anesthesia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global General Anesthesia Drugs Market Share by Application 2025 VS 2032 Figure 37. North America General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 48. North America General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 52. Europe General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 56. Asia-Pacific General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 60. Latin America General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 64. Middle East and Africa General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. General Anesthesia Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. General Anesthesia Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Etomidate
  • Midazolam
  • Sevoflurane
  • Isoflurane
  • Others
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Astrazeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Maruishi
  • Piramal
  • Hikma Pharmaceuticals
  • Mylan
  • Nhwa
  • Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 General Anesthesia Drugs Market by Type
  6. 1.3.1 Propofol
  7. 1.3.2 Etomidate
  8. 1.3.3 Midazolam
  9. 1.3.4 Sevoflurane
  10. 1.3.5 Isoflurane
  11. 1.3.6 Others
  12. 1.4 Global General Anesthesia Drugs Market Size by Type
  13. 1.4.1 Global General Anesthesia Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global General Anesthesia Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global General Anesthesia Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 General Anesthesia Drugs Industry Trends
  2. 2.2 General Anesthesia Drugs Industry Drivers
  3. 2.3 General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 General Anesthesia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by General Anesthesia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by General Anesthesia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by General Anesthesia Drugs Price (2021-2026)
  4. 3.4 Global General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Anesthesia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global General Anesthesia Drugs Company, Product Type & Application
  7. 3.7 Global General Anesthesia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 General Anesthesia Drugs Regional Status and Outlook
  1. 4.1 Global General Anesthesia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global General Anesthesia Drugs Historic Market Size by Region
  3. 4.2.1 Global General Anesthesia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global General Anesthesia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global General Anesthesia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global General Anesthesia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global General Anesthesia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 General Anesthesia Drugs by Application
  1. 5.1 General Anesthesia Drugs Market by Application
  2. 5.1.1 Intravenous Anesthetics
  3. 5.1.2 Inhalational Anesthetics
  4. 5.2 Global General Anesthesia Drugs Market Size by Application
  5. 5.2.1 Global General Anesthesia Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global General Anesthesia Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global General Anesthesia Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astrazeneca
  2. 6.1.1 Astrazeneca Company Information
  3. 6.1.2 Astrazeneca Business Overview
  4. 6.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astrazeneca General Anesthesia Drugs Product Portfolio
  6. 6.1.5 Astrazeneca Recent Developments
  7. 6.2 Fresenius-Kabi
  8. 6.2.1 Fresenius-Kabi Company Information
  9. 6.2.2 Fresenius-Kabi Business Overview
  10. 6.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius-Kabi General Anesthesia Drugs Product Portfolio
  12. 6.2.5 Fresenius-Kabi Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AbbVie General Anesthesia Drugs Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 Baxter Healthcare
  20. 6.4.1 Baxter Healthcare Company Information
  21. 6.4.2 Baxter Healthcare Business Overview
  22. 6.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter Healthcare General Anesthesia Drugs Product Portfolio
  24. 6.4.5 Baxter Healthcare Recent Developments
  25. 6.5 B.Braun
  26. 6.5.1 B.Braun Company Information
  27. 6.5.2 B.Braun Business Overview
  28. 6.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 B.Braun General Anesthesia Drugs Product Portfolio
  30. 6.5.5 B.Braun Recent Developments
  31. 6.6 Maruishi
  32. 6.6.1 Maruishi Company Information
  33. 6.6.2 Maruishi Business Overview
  34. 6.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Maruishi General Anesthesia Drugs Product Portfolio
  36. 6.6.5 Maruishi Recent Developments
  37. 6.7 Piramal
  38. 6.7.1 Piramal Company Information
  39. 6.7.2 Piramal Business Overview
  40. 6.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Piramal General Anesthesia Drugs Product Portfolio
  42. 6.7.5 Piramal Recent Developments
  43. 6.8 Hikma Pharmaceuticals
  44. 6.8.1 Hikma Pharmaceuticals Company Information
  45. 6.8.2 Hikma Pharmaceuticals Business Overview
  46. 6.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio
  48. 6.8.5 Hikma Pharmaceuticals Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan General Anesthesia Drugs Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Nhwa
  56. 6.10.1 Nhwa Company Information
  57. 6.10.2 Nhwa Business Overview
  58. 6.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nhwa General Anesthesia Drugs Product Portfolio
  60. 6.10.5 Nhwa Recent Developments
  61. 6.11 Hengrui
  62. 6.11.1 Hengrui Company Information
  63. 6.11.2 Hengrui Business Overview
  64. 6.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hengrui General Anesthesia Drugs Product Portfolio
  66. 6.11.5 Hengrui Recent Developments
  67. 6.12 Lunan
  68. 6.12.1 Lunan Company Information
  69. 6.12.2 Lunan Business Overview
  70. 6.12.3 Lunan General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lunan General Anesthesia Drugs Product Portfolio
  72. 6.12.5 Lunan Recent Developments
7 North America by Country
  1. 7.1 North America General Anesthesia Drugs Sales by Country
  2. 7.1.1 North America General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America General Anesthesia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America General Anesthesia Drugs Market Size by Country
  6. 7.2.1 North America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe General Anesthesia Drugs Sales by Country
  2. 8.1.1 Europe General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe General Anesthesia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe General Anesthesia Drugs Market Size by Country
  6. 8.2.1 Europe General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific General Anesthesia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific General Anesthesia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific General Anesthesia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America General Anesthesia Drugs Sales by Country
  2. 10.1.1 South America General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America General Anesthesia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America General Anesthesia Drugs Market Size by Country
  6. 10.2.1 South America General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa General Anesthesia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa General Anesthesia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa General Anesthesia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 General Anesthesia Drugs Value Chain Analysis
  2. 12.1.1 General Anesthesia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 General Anesthesia Drugs Production Mode & Process
  7. 12.2 General Anesthesia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 General Anesthesia Drugs Distributors
  10. 12.2.3 General Anesthesia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst